Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Debt to Equity (2016 - 2025)

Historic Debt to Equity for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to $11.65.

  • STRATA Skin Sciences' Debt to Equity rose 62286.18% to $11.65 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.65, marking a year-over-year increase of 62286.18%. This contributed to the annual value of $3.06 for FY2024, which is 15769.96% up from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Debt to Equity is $11.65, which was up 62286.18% from $28.7 recorded in Q2 2025.
  • Over the past 5 years, STRATA Skin Sciences' Debt to Equity peaked at $28.7 during Q2 2025, and registered a low of $0.02 during Q2 2021.
  • For the 5-year period, STRATA Skin Sciences' Debt to Equity averaged around $3.09, with its median value being $0.89 (2023).
  • As far as peak fluctuations go, STRATA Skin Sciences' Debt to Equity plummeted by 7947.1% in 2021, and later surged by 170528.51% in 2025.
  • Quarter analysis of 5 years shows STRATA Skin Sciences' Debt to Equity stood at $0.29 in 2021, then increased by 18.91% to $0.34 in 2022, then skyrocketed by 246.24% to $1.19 in 2023, then soared by 157.7% to $3.06 in 2024, then surged by 281.33% to $11.65 in 2025.
  • Its Debt to Equity was $11.65 in Q3 2025, compared to $28.7 in Q2 2025 and $5.11 in Q1 2025.